Vor Biopharma (VOR) Treasury Shares (2022 - 2026)

Vor Biopharma (VOR) has 5 years of Treasury Shares data on file, last reported at $346325.0 in Q1 2026.

• Quarterly Treasury Shares changed N/A year-over-year to $346325.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $346325.0 (changed N/A YoY) and the FY2025 annual result came in at $186325.0, up 182.11% from the prior year.
• Treasury Shares improved to $346325.0 in Q1 2026 per VOR's latest filing, from $186325.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.4 million in Q4 2022 and bottomed at $66046.0 in Q4 2024.
• The 5-year median for Treasury Shares is $346325.0 (2026), against an average of $628455.4.
• The widest annual swing landed in 2024, when Treasury Shares sank 94.07%; it then jumped 182.11% in 2025.
• Tracing VOR's Treasury Shares over 5 years: stood at $1.4 million in 2022, then dropped by 22.15% to $1.1 million in 2023, then slumped by 94.07% to $66046.0 in 2024, then jumped by 182.11% to $186325.0 in 2025, then surged by 85.87% to $346325.0 in 2026.
• Per Business Quant, the three latest VOR Treasury Shares figures stand at $346325.0 (Q1 2026), $186325.0 (Q4 2025), and $66046.0 (Q4 2024).

Peer Comparison